Coloplast Statistics

Total Valuation

Coloplast has a market cap or net worth of EUR 24.12 billion. The enterprise value is 27.32 billion.

Market Cap	24.12B
Enterprise Value	27.32B

Important Dates

The last earnings date was Tuesday, February 4, 2025.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	Dec 6, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+2.97%
Shares Change (QoQ)	+0.22%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	141.39M

Valuation Ratios

The trailing PE ratio is 36.83.

PE Ratio	36.83
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.73, with an EV/FCF ratio of 114.64.

EV / Earnings	41.71
EV / Sales	7.42
EV / EBITDA	23.73
EV / EBIT	27.54
EV / FCF	114.64

Financial Position

The company has a current ratio of 0.81, with a Debt / Equity ratio of 1.60.

Current Ratio	0.81
Quick Ratio	0.49
Debt / Equity	1.60
Debt / EBITDA	2.88
Debt / FCF	13.93
Interest Coverage	8.97

Financial Efficiency

Return on equity (ROE) is 31.94% and return on invested capital (ROIC) is 12.02%.

Return on Equity (ROE)	31.94%
Return on Assets (ROA)	9.54%
Return on Invested Capital (ROIC)	12.02%
Return on Capital Employed (ROCE)	20.80%
Revenue Per Employee	221,357
Profits Per Employee	39,385
Employee Count	16,639
Asset Turnover	0.57
Inventory Turnover	2.48

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.07% in the last 52 weeks. The beta is 0.37, so Coloplast's price volatility has been lower than the market average.

Beta (5Y)	0.37
52-Week Price Change	-10.07%
50-Day Moving Average	108.07
200-Day Moving Average	115.29
Relative Strength Index (RSI)	47.56
Average Volume (20 Days)	221

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Coloplast had revenue of EUR 3.68 billion and earned 654.89 million in profits. Earnings per share was 2.91.

Revenue	3.68B
Gross Profit	2.48B
Operating Income	992.12M
Pretax Income	886.32M
Net Income	654.89M
EBITDA	1.11B
EBIT	992.12M
Earnings Per Share (EPS)	2.91

Full Income Statement

Balance Sheet

The company has 121.48 million in cash and 3.32 billion in debt, giving a net cash position of -3.20 billion.

Cash & Cash Equivalents	121.48M
Total Debt	3.32B
Net Cash	-3.20B
Net Cash Per Share	n/a
Equity (Book Value)	2.07B
Book Value Per Share	9.21
Working Capital	-321.68M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 400.25 million and capital expenditures -161.98 million, giving a free cash flow of 238.27 million.

Operating Cash Flow	400.25M
Capital Expenditures	-161.98M
Free Cash Flow	238.27M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 67.45%, with operating and profit margins of 26.95% and 17.79%.

Gross Margin	67.45%
Operating Margin	26.95%
Pretax Margin	24.08%
Profit Margin	17.79%
EBITDA Margin	30.24%
EBIT Margin	26.95%
FCF Margin	6.47%

Dividends & Yields

This stock pays an annual dividend of 2.95, which amounts to a dividend yield of 2.76%.

Dividend Per Share	2.95
Dividend Yield	2.76%
Dividend Growth (YoY)	4.69%
Years of Dividend Growth	6
Payout Ratio	101.47%
Buyback Yield	-2.97%
Shareholder Yield	-0.21%
Earnings Yield	2.72%
FCF Yield	0.99%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Coloplast has an Altman Z-Score of 5.07.

Altman Z-Score	5.07
Piotroski F-Score	n/a